Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis
Authors:
- T YamadaTYT Yamada
- Y OkudaYOY Okuda
- K TakasugiKTK Takasugi
- K ItohKIK Itoh
Open Access
- 1 February 2001
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (2) , 124-127
Abstract
OBJECTIVES (1) To determine whether serum concentration of serum amyloid A (SAA) protein is influenced by the SAA1 allele in Japanese patients with rheumatoid arthritis (RA) as previously shown in a healthy control group; and (2) to analyse what factors, based on such an allelic bias, influence the relative SAA values of those patients. METHODS SAA and C reactive protein (CRP) concentrations together with SAA1 genotypes were determined in 316 Japanese patients with RA. The relative SAA values were evaluated as an SAA/CRP ratio. RESULTS Comparison of the three SAA1 homozygote groups showed that the SAA/CRP ratio was highest in the 1.5/1.5 group (mean 9.0, pv the other two homozygote groups) followed by the 1.3/1.3 group (mean 7.2, NS v the 1.1/1.1 group) and the 1.1/1.1 group (mean 4.0). The SAA/CRP ratio was significantly higher in patients receiving corticosteroids regardless of the presence of allele 1.5. No clear differences in the ratio between patients with or without amyloidosis were found. CONCLUSION The SAA1.5 allele and corticosteroid treatment had a positive influence on SAA concentrations in serum. These findings are important when evaluating SAA concentration in inflammatory diseases and when considering the cause or treatment of amyloidosis.Keywords
This publication has 26 references indexed in Scilit:
- C-REACTIVE PROTEIN AND SERUM AMYLOID A mRNA STABILITY FOLLOWING INDUCTION BY CYTOKINESCytokine, 1996
- SECONDARY AMYLOIDOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DIAGNOSTIC AND PROGNOSTIC VALUE OF GASTRODUODENAL BIOPSYRheumatology, 1996
- A novel allelic variant of serum amyloic A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA– amyloidosisHuman Molecular Genetics, 1995
- Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- The acute phase responseImmunology Today, 1994
- Serum amyloid A protein in acute viral infections.Archives of Disease in Childhood, 1993
- Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patientsJournal of Clinical Laboratory Analysis, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1986